Moxonidine, an Antihypertensive Agent, is Permissive to α 1-Adrenergic Receptor Pathway in the Rat-Tail Artery

Journal of Cardiovascular Pharmacology

Volumn 43, Issue 2, 2004, Pages 306-311

  George, Oommen K ^a   Gonzalez Jr , Ramon R ^a   Edwards, Lincoln P ^a  

^a LOMA LINDA UNIVERSITY   (United States)

Author keywords

1 adrenoceptor; Artery; Contractile; Moxonidine; Rat tail

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; EFAROXAN; IMIDAZOLINE; MOXONIDINE; PHENYLEPHRINE; PRAZOSIN; URAPIDIL; YOHIMBINE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; TAIL ARTERY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DRUG INTERACTIONS; IMIDAZOLES; MALE; MUSCLE, SMOOTH, VASCULAR; PIPERAZINES; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; VASOCONSTRICTION; YOHIMBINE;

EID: 1642459106     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200402000-00022     Document Type: Article

References (16)

1. Ziegler D, Haxhiu MA, Kaan EC, et al. Pharmacology of moxonidine. J Cardiovasc Pharmacol. 1996;27:S26.
2. Armah BI, Hofferber E, Stnezel W. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Arzneim Forsch. 1988;38:1426-1434.
3. 1-imidazoline sites. J Pharmacol Exp Ther. 1993;264:172-182.
4. Davies DS, Wing AM, Reid JL, et al. Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine. Clin Pharmacol Ther. 1977;21:593-601.
5. 1-imidazoline receptor agonist. J Cardiovasc Pharmacol. 2000;35(Suppl 4):S27-S41.
6. 1-imidazoline receptors in the rostral ventrolateral medulla. J Cardiovasc Pharmacol. 1994;24(Suppl 1): S1-S8.
7. Allan DR, Penner SB, Smyth DD. Renal imidazoline preferring sites and solute excretion in the rat. Br J Pharmacol. 1993;108:870-875.
8. Bidet M, Poujeol P, Parini A. Effect of imidazolines on Na+ transport and intracellular pH in renal proximal tubule cells. Biochim Biophys Acta. 1990;1024:173-178.
9. El-Ayoubi R, Gutkowska J, Regunathan S, et al. Imidazoline receptors in the heart: Characterization, distribution, and regulation. J Cardiovasc Pharmacol. 2002;39:875-883.
10. 1-adrenergic receptors. Jpn J Pharmacol. 2000;84:1-6.
11. Cheung Y, Triggle CR. Alpha adrenoceptor sites in vascular smooth muscle differentiation by selective antagonist binding. Biochem Pharmacol. 1988;37:4055-4061.
12. Langer SZ, Hicks PE. Alpha-adrenoceptors subtypes in blood vessels: physiology and pharmacology. J Cardiovasc Pharmacol. 1984;6(Suppl. 4):S547-S558.
13. Leech CJ, Faber JE. Different α-adrenoceptor subtype mediates constriction of arterioles and venules. Am J Physiol. 1996;270:H710-H722.
14. Price JD, David L, Krauss EB. Length dependent sensitivity in vascular smooth muscle. Am J Physiol. 1962;177:H557-H563.
15. Medgett IC, Langer SZ. Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro. J Pharmacol Exp Ther. 1984;229:823-830.
16. Savino EA, Varela A. Characterization of postsynaptic alpha-adrenoceptors in the isolated rat-tail artery. Arch Int Pharmacodyn Ther. 1991;309:137-146.